Dr. Andrew Landstrom is a physician-scientist and Professor of Pediatrics at the Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine who specializes in heritable arrhythmias and cardiomyopathies. He received his MD and PhD from the Mayo Clinic College of Medicine, where his graduate work investigated the genetic and cellular mechanisms underlying cardiomyopathies.  He subsequently completed residency training in pediatrics, fellowship training in pediatric cardiology, and advanced training in pediatric electrophysiology at Texas Children’s Hospital and Baylor College of Medicine.  With this training background, Dr. Landstrom focuses clinically on the care of children and families with heritable heart conditions, particularly inherited arrhythmia syndromes, sudden cardiac arrest evaluations, and post-mortem genetic evaluations. As an NIH-funded investigator, his research program works to define the molecular and genetic mechanisms that drive heritable arrhythmias and cardiomyopathies, with the goal of developing precision- and gene-based therapies. His research bridges basic and clinical investigation through translational and clinical research efforts, including genomic prediction modeling to anticipate the development of arrhythmias, cardiomyopathies, and heart failure. The overarching goal of his work is to identify and treat life threatening cardiac disease before it manifests clinically. In this capacity, he serves as Director of Translational Research for the Cardiovascular Institute at CHOP, where he facilitates the translation of basic scientific discovery into clinical application to accelerate the development of transformative therapies for children with inherited heart disease.